Back to the directory
Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
- Founded
- 2018
- Status
- Active
- Stage
- Early
- Team size
- 15
- Location
- San Francisco, CA, USA
- Category
- Biotech & Drug Discovery
- Sector
- Drug Discovery and Delivery
About Algen Biotechnologies
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
AI-powered Drug DiscoveryArtificial IntelligenceCRISPR
Federal research funding
1 NIH award totalling $350,000, FY2021.
- AlgenML: Drug target discovery platform for transcriptional reprogramming of MYCN-driven neuroblastoma
Source: NIH RePORTER.
Company data compiled and maintained by Healthcare Discovery.
